Here’s another edition of our chart-based weekly with our FinTwit friend Rhum.
Every week he breaks down the weekly charts from some of the hottest tickers out there. These charts will show you some of the most hyped-up names of the week, and maybe even a few that might be good buying opportunities.
If you like the charts, don’t forget to support Rhum and his blog for his hard work and don’t hesitate to send in any chart requests either.
META – Bounce Off Dilution?
After announcing a dilutive financing to stay liquid, we take a look at beleaguered cannabis retailer Meta Growth (TSXV: META).
While the outlook is questionable, there is the potential for a bounce if you believe cannabis retail bulls still have gun powder. With MedMen casting a grim shadow over retailers, smarter money would stay away until more stores have been opened.
AEM – Breakthrough Approval Breaks Downtrend?
Agnico Eagle (TSX: AEM) is one of the world’s largest gold miners and deserving of a place in your portfolio if you are looking to increase your “insurance” weighting. The bigger picture is very bullish, any near term cooling could present a solid buying opportunity.
LHS – A Wait And See Ahead of Earnings?
Liberty Health Sciences (CSE: LHS) may be releasing earnings this week. The overall chart is suggesting traders should wait for a signal as the market sentiment from earnings will likely have a significant impact.
However, based on recent performance, the positive upward trend, and news of impending warrant cancellations, the overall outlook suggests LHS is well-positioned.
AII – Volume Indicator Signals
Almonty Industries (TSX: AII) is a global mining company focused on the production and exploration of tungsten.
The chart from the past week is suggesting the recent downtrend could break with heavy volume signalling a surge in previous weeks.
If you appreciated the chart commentary by Rhum, keep in mind this isn’t his day job and he’s doing this to help investors. If you’ve made money based on his charting, don’t be afraid to give a little back.
The opinions provided in this article are those of the author and do not constitute investment advice. Readers should assume that the author and/or employees of Capital 10X hold positions in the company or companies mentioned in the article. For more information, please see our Content Disclaimer.